The efficacy and safety of ginger (Zingiber officinale) rhizome extract in outpatients with COVID-19: A randomized double-blind placebo-control clinical trial.

Ali AmeriMehdi FarashahinejadParivash DavoodianOmid SafaMehdi HassaniazadMohsen ParsaiiBehnoosh HeidariSoheil HassanipourBoshra AkhlaghiMohammad Fathalipour

Published in: Medicine (2024)

The trial was registered as IRCT20200506047323N1.

Keyphrases

phase iii
double blind
clinical trial
phase ii
placebo controlled
coronavirus disease
sars cov
study protocol
open label
oxidative stress
respiratory syndrome coronavirus